Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial
Witzig, T E, Tobinai, K, Rigacci, L, Ikeda, T, Vanazzi, A, Hino, M, Shi, Y, Mayer, J, Costa, L. J, Bermudez Silva, C D, Zhu, J, Belada, D, Bouabdallah, K, Kattan, J G, Kuruvilla, J, Kim, W S, LaroucheLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx764
Date:
December, 2017
File:
PDF, 956 KB
english, 2017